“Not Possible To Get COVID–19 Twice”
PETER A. McCULLOUGH, MD, MPH,FACP, FACC, FCCP, FAHA, FNKF, FNLA, FCRSA
After receiving a bachelor’s degree from Baylor University, Dr. McCullough
completed his medical degree as an Alpha Omega Alpha graduate from the
University of Texas Southwestern Medical School. He went on to complete his
internal medicine residency at the University of Washington, cardiology
fellowship including service as Chief Fellow at William Beaumont Hospital, and
master’s degree in public health at the University of Michigan. Dr. McCullough is
a practicing internist and cardiologist in Dallas, TX. He was formerly a Professor
of Medicine at Texas A & M College of Medicine, Dallas campus.
Dr. McCullough has broadly published on a range of topics in medicine with > 1000 publications and >
600 citations in the National Library of Medicine. His works include the “Interface between Renal
Disease and Cardiovascular Illness” in Braunwald’s Heart Disease Textbook. Dr. McCullough is a recipient
of the Simon Dack Award from the American College of Cardiology and the International Vicenza Award
in Critical Care Nephrology for his scholarship and research.
Dr. McCullough is a founder and current president of the Cardiorenal Society of America, an
organization dedicated to bringing cardiologists and nephrologists together to work on the emerging
problem of cardio renal syndromes. His works have appeared in the New England Journal of Medicine,
Journal of the American Medical Association, Lancet, British Medical Journal and other top–tier journals
worldwide.
He is also an epidemiologist and the editor–in–chief of Cardio renal Medicine, Reviews in Cardiovascular
Medicine, as well as senior associate editor of the American Journal of Cardiology. He serves on the
editorial boards of multiple specialty journals. Dr. McCullough has made presentations on the
advancement of medicine across the world and has been an invited lecturer at the New York Academy
of Sciences, the National Institutes of Health, U.S. Food and Drug Administration (FDA), and the
European Medicines Agency. He has served as member or chair of data safety monitoring boards of 24
randomized clinical trials.
Since the outset of the pandemic, Dr. McCullough has been a leader in the medical response to the
COVID–19 disaster and has published “Pathophysiological Basis and Rationale for Early Outpatient
Treatment of SARS–CoV–2 (COVID–19) Infection” the first synthesis of sequenced multi drug treatment of
ambulatory patients infected with SARS–CoV–2 in the American Journal of Medicine and subsequently
updated in Reviews in Cardiovascular Medicine. He has 40 peer–reviewed publications on the infection
and has commented extensively on the medical response to the COVID–19 crisis in The Hill and on FOX
NEWS Channel. On November 19, 2020, Dr. McCullough testified in the US Senate Committee on
Homeland Security and Governmental Affairs and throughout 2021 in the Texas Senate Committee on
Health and Human Services, Colorado General Assembly, and New Hampshire Senate concerning many
aspects of the pandemic response
After receiving a bachelor’s degree from Baylor University, Dr. McCullough
completed his medical degree as an Alpha Omega Alpha graduate from the
University of Texas Southwestern Medical School. He went on to complete his
internal medicine residency at the University of Washington, cardiology
fellowship including service as Chief Fellow at William Beaumont Hospital, and
master’s degree in public health at the University of Michigan. Dr. McCullough is
a practicing internist and cardiologist in Dallas, TX. He was formerly a Professor
of Medicine at Texas A & M College of Medicine, Dallas campus.
Dr. McCullough has broadly published on a range of topics in medicine with > 1000 publications and >
600 citations in the National Library of Medicine. His works include the “Interface between Renal
Disease and Cardiovascular Illness” in Braunwald’s Heart Disease Textbook. Dr. McCullough is a recipient
of the Simon Dack Award from the American College of Cardiology and the International Vicenza Award
in Critical Care Nephrology for his scholarship and research.
Dr. McCullough is a founder and current president of the Cardiorenal Society of America, an
organization dedicated to bringing cardiologists and nephrologists together to work on the emerging
problem of cardio renal syndromes. His works have appeared in the New England Journal of Medicine,
Journal of the American Medical Association, Lancet, British Medical Journal and other top–tier journals
worldwide.
He is also an epidemiologist and the editor–in–chief of Cardio renal Medicine, Reviews in Cardiovascular
Medicine, as well as senior associate editor of the American Journal of Cardiology. He serves on the
editorial boards of multiple specialty journals. Dr. McCullough has made presentations on the
advancement of medicine across the world and has been an invited lecturer at the New York Academy
of Sciences, the National Institutes of Health, U.S. Food and Drug Administration (FDA), and the
European Medicines Agency. He has served as member or chair of data safety monitoring boards of 24
randomized clinical trials.
Since the outset of the pandemic, Dr. McCullough has been a leader in the medical response to the
COVID–19 disaster and has published “Pathophysiological Basis and Rationale for Early Outpatient
Treatment of SARS–CoV–2 (COVID–19) Infection” the first synthesis of sequenced multi drug treatment of
ambulatory patients infected with SARS–CoV–2 in the American Journal of Medicine and subsequently
updated in Reviews in Cardiovascular Medicine. He has 40 peer–reviewed publications on the infection
and has commented extensively on the medical response to the COVID–19 crisis in The Hill and on FOX
NEWS Channel. On November 19, 2020, Dr. McCullough testified in the US Senate Committee on
Homeland Security and Governmental Affairs and throughout 2021 in the Texas Senate Committee on
Health and Human Services, Colorado General Assembly, and New Hampshire Senate concerning many
aspects of the pandemic response
